Table 1 Patient demographics and MRI features of different metastatic brain lesions
Patients, N | Age | Brain Lesion, N | Tumor Volume [μL] | ADC [μm 2 /ms] | rCBV (normalized to NAWM, a.u. ) | ||
Pathology | Breast | 27 | 56.0 (44–64) | 72 (1–3) | 300.0 (118.7–790.5) | 1.03 (0.91–1.26) | 2.14 (1.42–3.68) |
NSCLC | 43 | 65.0 (56–71) | 159 (1–4) | 236.0 (104.0–1120.0) | 1.12 (0.82–1.34) | 2.11 (1.09–3.41) | |
Other | 44 | 62.5 (55–72) | 115 (1–3) | 627.53 (182.0–2121.0) | 1.10 (0.88–1.42) | 2.0 (1.31–3.02) | |
Total | 114 | 60 (53.7–69.5) | 346 (1–3) | 318.52 (119.7–1340.9) | 1.09 (0.91–1.34) | 2.03 (1.23–3.39) | |
Arterial component (%) | Overlap (%) | Venous component (%) | |||||
Pathology | Breast | 27.33 (16.76–64.77) | 54.13 (18.51–77.53) | 54.39 (24.25–89.85) | |||
NSCLC | 32.57 (9.01–69.04) | 35.08 (11.61–59.93) | 24.18 (11.33–44.60) | ||||
Other | 15.12 (4.31–33.94) | 42.52 (20.99–64.14) | 24.11 (7.88–50.82) | ||||
Total | 23.84 (6.98–50.42) | 40.86 (17.11–65.84) | 29.21 (10.63–57.51) |